Group 1 - FOXO Technologies Inc. provides an update on Myrtle Recovery Centers, Inc. and its behavioral health facility in Oneida, Tennessee, confirming participation in a major addiction conference [1][3] - Myrtle Recovery Centers has achieved a stabilization in its Oneida facility, maintaining an occupancy rate of 75% or greater since the beginning of 2025, with some periods at full capacity [2] - The facility has finalized several in-network contracts with major managed care organizations since the start of 2025 [2] Group 2 - Myrtle Recovery Centers will participate as a Silver Sponsor in the ETAADAC Conference in Knoxville, TN, from March 19-21, 2025, which focuses on addiction counseling and treatment [3][4] - The ETAADAC Conference serves as a platform for professionals in addiction recovery to exchange ideas, share best practices, and discuss emerging trends [4] - The CEO of Myrtle Recovery Centers expressed satisfaction with the progress made since joining FOXO and highlighted the importance of the conference for collaboration and learning [5] Group 3 - FOXO Technologies Inc. operates three subsidiaries, including Myrtle Recovery Centers, which runs a 30-bed behavioral health facility providing various treatment services [6] - FOXO Labs, Inc. is a biotechnology company focused on improving human health and lifespan through innovative technology and product solutions [7]

Core Insights - FOXO Technologies Inc. has executed a non-binding acquisition agreement for two assisted living facilities in Florida, with each facility priced at approximately $30 million [1][2][3] - The acquisition is structured with milestone payments based on increased revenues at the facilities, indicating a focus on recurring revenue and cash flow models in the healthcare sector [3] Acquisition Details - The first facility has 129 units, while the second has 137 units, with a total expected purchase price of $60 million for both [2] - The parties aim to finalize definitive agreements within 60 days, with closing anticipated between 60 and 120 days after that, contingent on due diligence and financing [2] Company Strategy - The CEO of FOXO expressed optimism about the acquisitions, highlighting the potential for significant value creation and opportunities for shareholders through diversification in healthcare services [3] - The company plans to use this acquisition model to pursue additional value-added acquisitions in the future [3] Company Overview - FOXO operates three subsidiaries, including Rennova Community Health, which manages a critical access hospital, and Myrtle Recovery Centers, which provides behavioral health services [4] - FOXO Labs focuses on biotechnology aimed at improving human health and lifespan through innovative technology and product solutions [5]

Core Viewpoint - FOXO Technologies Inc. has undergone significant changes and improvements, positioning itself for a successful turnaround and future growth in 2025 and beyond [1][6]. Financial Performance - The company has transitioned from minimal net revenues to acquiring businesses that could potentially generate over $20 million in profitable net revenues annually with further investment [2]. - As of September 30, 2024, FOXO disclosed a shareholders deficit exceeding $17 million, but has since restructured a substantial amount of debt to equity, resulting in an improvement of over $21 million in shareholders' equity [3]. Business Strategy - For 2025, the company aims to grow its acquired rural hospital and behavioral health businesses while monetizing its epigenetics division [4]. - FOXO is actively seeking additional acquisition opportunities in the healthcare sector, including senior living [4]. Business Operations - FOXO operates three subsidiaries: FOXO Labs, a biotechnology company focused on epigenetic biomarker discovery; Myrtle Recovery Centers, a behavioral health facility; and Rennova Community Health, which operates a critical access hospital [7][8]. - Myrtle Recovery Centers, which opened in August 2023, aims to achieve annual net revenues of approximately $3-4 million and plans to replicate its service model in other locations [6]. Future Outlook - The company is considering options to create shareholder value, including a potential spin-out of its epigenetics business [5]. - FOXO is in preliminary discussions for additional acquisitions that could enhance shareholder value, although no agreements have been finalized [5].

Core Points - FOXO Technologies Inc. will hold a Special Meeting of its Shareholders on January 17, 2025, at 10:30 am EST [1] - Shareholders of record as of January 3, 2025, are entitled to vote on the proposals [2] - Voting can be done via the internet or by attending the virtual meeting using a control number [3] - The CEO of FOXO expressed anticipation for shareholder support and highlighted the importance of the meeting in relation to recent acquisition agreements [4] Company Overview - FOXO Technologies Inc. operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. [5][6] - Foxo Labs focuses on biotechnology aimed at improving human health and lifespan [5] - Myrtle Recovery Centers provides behavioral health services, including inpatient and outpatient treatment [5] - Rennova Community Health operates a critical access hospital in East Tennessee [6]

Core Viewpoint - FOXO Technologies Inc. is holding a special shareholder meeting on January 17, 2025, to seek approval for several proposals related to acquisition transactions [1][2]. Shareholder Meeting Details - The special meeting will take place virtually at 10:30 a.m. EST, with a record date of January 3, 2025, allowing all shareholders of record on that date to vote [2]. - The main proposal involves the issuance of shares of Class A Common Stock upon conversion of Series A Preferred Stock, which may constitute a "Change of Control" as defined by NYSE American Rules [8]. Company Overview - FOXO operates three subsidiaries: - Foxo Labs, Inc., focused on biotechnology and improving human health through innovative technology [5]. - Myrtle Recovery Centers, Inc., a behavioral health facility providing various treatment services [5]. - Rennova Community Health, Inc., which operates a critical access hospital in East Tennessee [6]. CEO Statement - The CEO, Seamus Lagan, expressed the importance of shareholder support for the proposals and emphasized the company's focus on revenue growth and potential acquisition opportunities post-meeting [4].

Core Viewpoint - FOXO Technologies Inc. is holding a special shareholder meeting on January 17, 2025, to seek approval for several proposals related to acquisition transactions [1][2]. Group 1: Shareholder Meeting Details - The special meeting will take place virtually at 10:30 a.m. EST, and shareholders of record as of January 3, 2025, are entitled to vote [2]. - The main proposal involves the issuance of shares of Class A Common Stock related to the Series A Cumulative Convertible Redeemable Preferred Stock [8]. Group 2: Company Overview - FOXO operates three subsidiaries: Foxo Labs, Inc., which focuses on biotechnology and health solutions; Myrtle Recovery Centers, Inc., a behavioral health facility; and Rennova Community Health, Inc., which operates a critical access hospital [5][6]. Group 3: Executive Statement - The CEO of FOXO expressed the importance of shareholder support for the proposals to focus on revenue growth and potential acquisition opportunities post-meeting [4]. Group 4: Proposals for Approval - The proposals include: 1. Approval for the issuance of shares of Class A Common Stock upon conversion of Series A Preferred Stock [8]. 2. Approval for the adjournment of the meeting if necessary to solicit additional proxies [8]. 3. Consideration of other matters that may arise during the meeting [8].

Company Overview - FOXO Technologies Inc. is a biotechnology company focused on enhancing human health and lifespan through innovative technology and product solutions across various industries [4]. Annual General Meeting - The 2024 Annual General Meeting of FOXO will take place virtually on December 31, 2024, at 9:30 am CST, allowing shareholders to vote and submit questions online [2][8]. - Shareholders of record on December 19, 2024, will be eligible to vote on the proposals presented [1]. Board of Directors and Proposals - The Board of Directors encourages shareholders to vote in favor of the proposals outlined in the Definitive Proxy Statement filed with the SEC [3]. - The CEO of FOXO, Seamus Lagan, expressed the importance of shareholder approval for directors and auditors during the upcoming meeting [8]. Business Developments - FOXO has addressed all deficiencies related to its NYSE American continued listing requirements and has acquired significant revenue-generating businesses [8]. - The company is pursuing an acquisition and growth strategy aimed at driving substantial growth and value in 2025 and beyond [8].

Core Viewpoint - FOXO Technologies Inc. has regained compliance with NYSE American listing requirements for stockholders equity, reporting stockholders equity greater than $4 million following recent transactions [1][3]. Financial Summary - As of September 30, 2024, the company had a stockholders' deficit of approximately $17.5 million [2]. - The company successfully exchanged $21 million of Senior Secured Notes into 21,000 shares of Series A Preferred Stock [3]. - An institutional investor provided an additional $1 million and exchanged approximately $2.2 million of Senior Notes into 2,464 shares of Series A Preferred Stock [3]. - The company settled certain liabilities with KR8 AI, Inc. in exchange for 3,000 shares of Series D Preferred Stock [3]. - Approximately $1 million of other liabilities and notes were converted into approximately 2 million shares of Class A Common Stock since October 1, 2024 [3]. Company Actions - The company filed a Current Report on Form 8-K with the SEC on December 10, 2024, detailing the transactions and related actions [4]. - The CEO expressed optimism about the company's future growth and commitment to shareholder benefits [3]. Company Overview - FOXO Technologies Inc. operates three subsidiaries, including Foxo Labs, Inc., which focuses on biotechnology, and Myrtle Recovery Centers, Inc., a behavioral health facility [5]. - Rennova Community Health, Inc. operates a critical access hospital in East Tennessee [6].

MINNEAPOLIS, MN, Nov. 25, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold its previously announced Special Meeting of its Shareholders at 10:30 am EST on Friday, November 29, 2024. Following the filing of its Definitive Proxy Statement filed with the SEC on November 15, 2024, the Company is holding a virtual meeting of its shareholders (the “Special Meeting”) on Friday, November 29, 2024, at 10:30 a.m. Eastern Standard Time. Shareholders of record o ...

MINNEAPOLIS, MN, Aug. 08, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company"), today announced that its recently acquired subsidiary, Myrtle Recovery Centers, Inc. ("Myrtle"), has been granted two full licenses from the Tennessee Department of Mental Health and Substance Abuse Services, effective August 1, 2024, for 12 months. The first license authorizes the provision of services for alcohol and drug residential detoxification treatment, as well as alcohol and drug residen ...